GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,305.00
-130.00 (-3.78%)
At close: Jun 19, 2026
GC Medical Science Market Cap
GC Medical Science has a market cap or net worth of 71.86 billion as of June 18, 2026. Its market cap has decreased by -21.37% in one year.
Market Cap
71.86B
Enterprise Value
92.41B
Revenue
105.48B
Ranking
n/a
PE Ratio
19.16
Stock Price
3,305.00
Market Cap Chart
Since December 17, 2014, GC Medical Science's market cap has decreased from 98.95B to 71.86B, a decrease of -27.38%. That is a compound annual growth rate of -2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 71.86B | -17.48% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 229.34B |
| 3billion | 213.85B |
| GENINUS | 97.41B |
| Cytogen | 88.59B |
| Inventera | 77.40B |
| HLB Panagene | 66.02B |
| Protia | 52.81B |
| Seoulin Bioscience | 44.71B |